the aid library

LIST OPTIONS

Filter

2026

Практический справочник ВОЗ по туберкулезу. Модуль 4. Лечение. Лечение лекарственно-устойчивого туберкулеза

World Health Organization WHO (2021) C_WHO

The consolidated guidelines are complemented by an operational handbook which is designed to assist with implementation of the WHO recommendations by Member States, technical partners and others who are involved in the management of patients with DR-TB. The WHO Operational Handbook on Tuberculosis, ... more

Download (592)

View PDF (445)

Manual de Normas y Procedimientos para el Control de la Tuberculosis en Ecuador, 2da Edicion

Chang Campos, C.; R. Cañizares Fuentes,J. Cuenca Vega et al. Ministerio de Salud Publica (2010) CC

Ministry of Public Health Tuberculosis Control Programme. Manual of Standards and procedures for the control of Tuberculosis in Ecuador, second edition.

Download (469)

View PDF (659)

Tuberculosis prevention and care among refugees and other populations in humanitarian settings: an interagency field guide
recommended

World Health Organization WHO, CDC, UNHCR (2022) C_WHO

Download (332)

View PDF (249)

Saude mental relacoes raciais e Covid 19

Lanari L., K. Y. Poli dos Santos Saúde mental, relações raciais e Covid - 19 (2020) C2

Saude mental relacoes raciais e Covid 19

Download (430)

View PDF (500)

Trypanosomiase humaine africaine : lutte et surveillance

World Health Organization WHO (2014) C_WHO

Un comité OMS d’experts sur la trypanosomiase humaine africaine (THA) : lutte et surveillance, s’est réuni à Genève (Suisse), du 22 au 26 avril 2013. Le Dr H. Nakatani, sous-directeur général pour le VIH/SIDA, la tuberculose, le paludisme et les maladies tropicales négligées, a ouvert la... more

External Link

Elimination of onchocerciasis in Africa by 2025: the need for a broad perspective

Cupp, E.; Sauerbrey, M.; Cama, V. et al. National Library of Medicine (2019) CC

In response to the recent publication “Is onchocerciasis elimination in Africa feasible by 2025: a perspective based on lessons learnt from the African control programmes” by Dadzie et al., it is important to clarify and highlight the positive and unequivocal research and operational contributio... more

Download (330)

View PDF (334)

Human African trypanosomiasis. Seminar

Büscher P., Cecchi G., Jamonneau V. et al (2017) C2

The Lancet Volume 390, Issue 10110p2397-2409November 25, 2017. Human African trypanosomiasis (HAT), also called sleeping sickness, is a parasitic infection that almost invariably progresses to death, unless treatment is provided. HAT caused devastating epidemics during the 20th century. Thanks to ... more

External Link

Comprehensive COVID-19 Slideset: Symptoms and Clinical Manifestations

Clinical Care Options (2021) CC

26 March 2021 Slideset updated regularly to include the latest data on the evolution and duration of COVID-19 symptoms and prevalence and duration of natural immunity.

Download (4696)

View PDF (3669)

Standard Treatment Guidelines. Nigeria

Federal Ministry of Health Nigeria , World Health Organisation (WHO) (2008) C_WHO

Download (253)

View PDF (252)

National Tuberculosis and Leprosy Control Strategic Plan

Government of Malawi; Ministry of Health Malawi (2024) CC2

Malawi is a landlocked country with a surface area of 118,484 km2. Administratively, the country is divided into three regions, namely the Northern, Central and Southern regions. The country has 28 districts, which are further divided into traditional authorities (TA) ruled by chiefs. The TAs are su... more

Download (234)

View PDF (353)

Mpox Testing Strategy - November 2024

Africa Center for Disease Control and Prevention (2024) CC

Mpox is an emerging zoonotic disease caused by the mpox virus, a member of the Orthopoxvirus genus closely related to the variola virus that causes smallpox. Mpox was first discovered in 1958 when outbreaks of a pox-like disease occurred in monkeys kept for research. The first human case was recorde...d in 1970 in the Democratic Republic of the Congo (DRC) during a period of intensified effort to eliminate smallpox and since then the infection has been reported in a number of African countries. Mpox can spread in humans through close contact, usually skin-to-skin contact, including sexual contact, with an infected person or animal, as well as with materials contaminated with the virus such as clothing, beddings and towels, and respiratory droplets in prolonged face to face contact. People remain infectious from the onset of symptoms until all the lesions have scabbed and healed. The virus may spread from infected animals through handling infected meat or through bites or scratches. Diagnosis is confirmed by polymerase chain reaction (PCR) testing of material from a lesion for the virus’s DNA. Two separate clades of the mpox virus are currently circulating in Africa: Clade I, which includes subclades Ia and Ib, and Clade II, comprising subclades IIa and IIb. Clade Ia and Clade Ib have been associated with ongoing human-to-human transmission and are presently responsible for outbreaks in the Democratic Republic of the Congo (DRC), while Clade Ib is also contributing to outbreaks in Burundi and other countries. In 2022‒2023 mpox caused a global outbreak in over 110 countries, most of which had no previous history of the disease, primarily driven by human-to-human transmission of clade II through sexual contact. In just over a year, over 90,000 cases and 150 deaths were reported to the WHO. For the second time since 2022, mpox has been declared a global health emergency as the virus spreads rapidly across the African continent. On 13 Aug 2024, Africa CDC declared the ongoing mpox outbreak a Public Health Emergency of Continental Security (PHECS), marking the first such declaration by the agency since its inception in 2017.7 This declaration empowered the Africa CDC to lead and coordinate responses to the mpox outbreak across affected African countries. On August 14, 2024, the WHO declared the resurgence of mpox a Public Health Emergency of International Concern (PHEIC) emphasizing the need for coordinated international response. As of August 2024, Mpox has expanded beyond its traditional endemic regions, with new cases reported in countries including Sweden, Thailand, the Philippines, and Pakistan. Sweden has confirmed its first case of Clade 1 variant, which has been rapidly spreading in Africa, particularly in DRC. The emergence of this new variant raises concerns about its potential for higher lethality and transmission rates outside Africa. more

Download (475)

View PDF (364)

WHO manual for HIV drug resistance testing using dried blood spot specimens

World Health Organization WHO (2020) C_WHO

HIV-1 drug resistance (HIVDR) genotyping is an essential component of the WHO global HIVDR surveillance strategy. Plasma “gold standard” specimen type for HIVDR genotyping, but its use may not be feasible in rural, remote areas in low- and middle-income countries, since preparing and storing it ... more

Download (354)

View PDF (474)

Situational Analysis of Antimicrobial Use and Resistance in Humans and Animals in Zimbabwe

The Center for Disease Dynamics, Economics & Policy CDDEP (2017) C2

This situation analysis has gathered information about the current state of AMR, contributing factors and antimicrobial use in Zimbabwe from the human, animal, agricultural and environmental sectors. Data has been gathered from different sectors such as the general public, academia, the Ministry of ... more

Download (610)

View PDF (508)

Analysis of the epidemiological impact of tuberculosis in Georgia

A. Hovhannesyan, P. Moonan, A. Dadu World Health Organization Europe (2015) C_WHO

Download (322)

View PDF (538)

Same-day diagnosis of tuberculosis by microscopy

World Health Organization (2011) C_WHO

Policy statement.

Download (521)

View PDF (678)

Vector control and the elimination of gambiense human African trypanosomiasis

World Health Organization WHO (2022) C_WHO

The main purpose of the meeting was to review tsetse control tools, activities and their contribution to the elimination of gHAT and the monitoring thereof. Seven endemic countries provided reports on recent and ongoing vector control interventions at the national level (Angola, Cameroon, Côte d’... more

Download (517)

View PDF (852)

Comparison of sensitivity and specificity of three diagnostic tests to detect Schistosoma mansoni infections in school children in Mwanza Region, Tanzania

Fuss, A.; H.D. Mazigo; D. Tappe, C.Kasang, A. Mueller (2018) CC

PLoS ONE 13(8): e0202499. https://doi.org/10.1371/journal.pone.0202499 This was a school-based cross-sectional study conducted in 2015 among 305 school children aged 7–16 years from two primary schools located in Ilemela and Magu Districts, north-western Tanzania. Single stool and urine samples w... more

External Link

Measuring the availability of human resources for health and its relationship to universal health coverage for 204 countries and territories from 1990 to 2019
recommended

GBD 2019 Human Resources for Health Collaborators The Lancet (2022) CC

A systematic analysis for the Global Burden of Disease Study 2019. The Lancet Vol.399 Issue 10341 p.2129-2154 Human resources for health (HRH) include a range of occupations that aim to promote or improve human health. The UN Sustainable Development Goals (SDGs) and the WHO Health Workforce 2030 s... more

Download (1900)

View PDF (1860)

Evaluation of integrated community case management for malaria, pneumonia, diarrhoea and newborn health in eight districts of central Uganda

Laura Gover, Andrew Anguko, Jane Bruce, Godfrey Magumba, et al. Malaria Consortium (2011) CC

Tuberculosis prevention and care among refugees and other populations in humanitarian settings: an interagency field guide recommended

Measuring the availability of human resources for health and its relationship to universal health coverage for 204 countries and territories from 1990 to 2019 recommended

Tuberculosis prevention and care among refugees and other populations in humanitarian settings: an interagency field guide
recommended

Measuring the availability of human resources for health and its relationship to universal health coverage for 204 countries and territories from 1990 to 2019
recommended